Real-World Medical Cost Avoidance When New Oral Anticoagulants are Used Versus Warfarin for Venous Thromboembolism in the United States

Objective: Real-world medical cost avoidances from a US payer perspective were estimated when new oral anticoagulants (NOACs) are used instead of warfarin for the treatment of patients with venous thromboembolism (VTE). Methods: Reductions in real-world event rates of recurrent VTE and MB were obtai...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical and Applied Thrombosis/Hemostasis 2016-01, Vol.22 (1), p.5-11
Hauptverfasser:	Amin, Alpesh, Bruno, Amanda, Trocio, Jeffrey, Lin, Jay, Lingohr-Smith, Melissa
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Anticoagulants Anticoagulants - economics Anticoagulants - therapeutic use Costs Costs and Cost Analysis Humans Monte Carlo Method Thromboembolism United States Venous Thromboembolism - drug therapy Venous Thromboembolism - economics Warfarin - economics Warfarin - therapeutic use
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!